1. β-Blockers in Chronic Heart Failure: Considerations for Selecting an Agent 
Marrick L. Kukin, MD 
Mayo Clinic Proceedings 
Volume 77, Issue 11, Pages (November 2002)
DOI: /
Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1
Kaplan-Meier curve of cumulative percentage of total mortality (P>.001) in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). P=.006 (adjusted); P>.001 (nominal). Reprinted with permission from Elsevier Science.5
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
Survival curve from the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) (P>.001). Reprinted with permission from Elsevier Science.4
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions

4. Figure 3
Kaplan-Meier analysis of survival from the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial (P=.001, adjusted). Reprinted with permission from Packer et al.7
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions